SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-20-030566
Filing Date
2020-02-11
Accepted
2020-02-11 07:00:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d856918dsc13ga.htm SC 13G/A 37884
  Complete submission text file 0001193125-20-030566.txt   39498
Mailing Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2
Business Address 30 WORCESTER ROAD TORONTO A6 M9W 5X2 416-798-3001
Intellipharmaceutics International Inc. (Subject) CIK: 0001474835 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1130
Type: SC 13G/A | Act: 34 | File No.: 005-85064 | Film No.: 20593846
SIC: 2834 Pharmaceutical Preparations

Mailing Address BAHNHOFSTRASSE 45 ZURICH V8 CH-8001
Business Address BAHNHOFSTRASSE 45 ZURICH V8 CH-8001 41-44-234-1111
UBS Group AG (Filed by) CIK: 0001610520 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks